Ma Xiaohua

1 month ago | yicaiglobal.com | Ma Xiaohua |Lin Zhiyin |Wu Simin

(Yicai) May 16 -- If the United States and China are forced to decouple in the pharmaceutical sector, this could push up US drugmakers’ costs by half, industry insiders said, in response to a recent statement by the US Treasury Secretary that although the US does not seek a full break from China, it does want to bring key industries like pharmaceuticals back to US soil.